Catalyst Wire Dossier Catalyst Wire Dossier

Spinraza

nusinersen · Biogen
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for Spinraza, covering 2016-12-23 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Spinraza (nusinersen sodium) — Biogen Netherlands B.V.

See pricing